Lgr5tm1.1(cre/ERT2)Npa
Targeted Allele Detail
|
Symbol: |
Lgr5tm1.1(cre/ERT2)Npa |
Name: |
leucine rich repeat containing G protein coupled receptor 5; targeted mutation 1.1, Novartis Pharma AG |
MGI ID: |
MGI:5635821 |
Synonyms: |
Lgr5-EGFP-IRES-CreERT2, Lgr5ki |
Gene: |
Lgr5 Location: Chr10:115286219-115423685 bp, - strand Genetic Position: Chr10, 63.51 cM
|
Alliance: |
Lgr5tm1.1(cre/ERT2)Npa page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:212415
|
Parent Cell Line: |
Not Specified (ES Cell)
|
Strain of Origin: |
C57BL/6
|
|
Allele Type: |
|
Targeted (Inducible, Null/knockout, Recombinase, Reporter) |
Inducer: |
|
tamoxifen |
Mutation: |
|
Insertion
|
|
|
Lgr5tm1.1(cre/ERT2)Npa expression driven by
1 gene
Knock-in expression driven by:
|
|
|
Mutation details: The targeting construct replaced the first 22 amino acids with an EGFP reporter gene, IRES, inducible cre recombinase fusion (cre/ERT2), polyadenylation sequence and FRT-flanked neomycin resistance cassette. Flp-mediated recombination removed the selection cassette. In situ hybridization confirmed the absence of transcript expression in the intestin, skin and kidney.
(J:212415)
|
|
|
Activity: |
Tissue activity of this recombinase allele
|
Driver:
|
Lgr5
(mouse)
|
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Lgr5 Mutation: |
57 strains or lines available
|
|
Original: |
J:212415 Kinzel B, et al., Functional roles of Lgr4 and Lgr5 in embryonic gut, kidney and skin development in mice. Dev Biol. 2014 Jun 15;390(2):181-90 |
All: |
5 reference(s) |
|